These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10802782)

  • 1. PET measures of benzodiazepine receptors in progressive supranuclear palsy.
    Foster NL; Minoshima S; Johanns J; Little R; Heumann ML; Kuhl DE; Gilman S
    Neurology; 2000 May; 54(9):1768-73. PubMed ID: 10802782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy.
    Juhász C; Nagy F; Watson C; da Silva EA; Muzik O; Chugani DC; Shah J; Chugani HT
    Neurology; 1999 Dec; 53(9):2037-45. PubMed ID: 10599778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy.
    Szelies B; Weber-Luxenburger G; Pawlik G; Kessler J; Holthoff V; Mielke R; Herholz K; Bauer B; Wienhard K; Heiss WD
    Neuroimage; 1996 Apr; 3(2):109-18. PubMed ID: 9345482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities.
    Foster NL; Gilman S; Berent S; Sima AA; D'Amato C; Koeppe RA; Hicks SP
    J Neurol Neurosurg Psychiatry; 1992 Aug; 55(8):707-13. PubMed ID: 1527543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation between cerebral glucose metabolism and benzodiazepine receptor density in the acute vegetative state.
    Rudolf J; Sobesky J; Ghaemi M; Heiss WD
    Eur J Neurol; 2002 Nov; 9(6):671-7. PubMed ID: 12453084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal correlates of clinical asymmetry in progressive supranuclear palsy.
    Amtage F; Hellwig S; Kreft A; Spehl T; Glauche V; Winkler C; Rijntjes M; Hellwig B; Weiller C; Weber WA; Tüscher O; Meyer PT
    Clin Nucl Med; 2014 Apr; 39(4):319-25. PubMed ID: 24566396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography.
    Hasler G; Nugent AC; Carlson PJ; Carson RE; Geraci M; Drevets WC
    Arch Gen Psychiatry; 2008 Oct; 65(10):1166-75. PubMed ID: 18838633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease.
    Meyer M; Koeppe RA; Frey KA; Foster NL; Kuhl DE
    Arch Neurol; 1995 Mar; 52(3):314-7. PubMed ID: 7872887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography.
    Foster NL; Gilman S; Berent S; Morin EM; Brown MB; Koeppe RA
    Ann Neurol; 1988 Sep; 24(3):399-406. PubMed ID: 3265862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease.
    Defebvre L; Lecouffe P; Destée A; Houdart P; Steinling M
    Acta Neurol Scand; 1995 Sep; 92(3):235-41. PubMed ID: 7484078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.
    Karbe H; Grond M; Huber M; Herholz K; Kessler J; Heiss WD
    J Neurol; 1992 Feb; 239(2):98-102. PubMed ID: 1552311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral blood flow, oxygen and glucose metabolism with PET in progressive supranuclear palsy.
    Otsuka M; Ichiya Y; Kuwabara Y; Miyake Y; Tahara T; Masuda K; Hosokawa S; Goto I; Kato M; Ichimiya A
    Ann Nucl Med; 1989 Nov; 3(3):111-8. PubMed ID: 2641456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
    Hosaka K; Ishii K; Sakamoto S; Mori T; Sasaki M; Hirono N; Mori E
    J Neurol Sci; 2002 Jul; 199(1-2):67-71. PubMed ID: 12084445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia.
    Garraux G; Salmon E; Degueldre C; Lemaire C; Laureys S; Franck G
    Neuroimage; 1999 Aug; 10(2):149-62. PubMed ID: 10417247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.
    Asahina M; Suhara T; Shinotoh H; Inoue O; Suzuki K; Hattori T
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):155-63. PubMed ID: 9703164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study on the cerebral glucose metabolism in progressive supranuclear palsy].
    Ma AJ; Guo XJ; Li DC; Zhang BS; Pan XD
    Zhonghua Nei Ke Za Zhi; 2012 Nov; 51(11):885-8. PubMed ID: 23291028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke.
    Heiss WD; Grond M; Thiel A; Ghaemi M; Sobesky J; Rudolf J; Bauer B; Wienhard K
    Stroke; 1998 Feb; 29(2):454-61. PubMed ID: 9472889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic study.
    Lingford-Hughes AR; Wilson SJ; Cunningham VJ; Feeney A; Stevenson B; Brooks DJ; Nutt DJ
    Psychopharmacology (Berl); 2005 Aug; 180(4):595-606. PubMed ID: 15864554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of disulfiram on positron emission tomography and neuropsychological studies in severe chronic alcoholism.
    Gilman S; Adams KM; Johnson-Greene D; Koeppe RA; Junck L; Kluin KJ; Martorello S; Heumann M; Hill E
    Alcohol Clin Exp Res; 1996 Nov; 20(8):1456-61. PubMed ID: 8947325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central benzodiazepine/gamma-aminobutyric acid A receptors in idiopathic generalized epilepsy: an [11C]flumazenil positron emission tomography study.
    Koepp MJ; Richardson MP; Brooks DJ; Cunningham VJ; Duncan JS
    Epilepsia; 1997 Oct; 38(10):1089-97. PubMed ID: 9579955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.